September 25, 2016 12:05 pm FDA OKs Muscular Dystrophy Drug Ed Kaye, President and CEO of Sarepta Therapeutics, joined necn to discuss the FDA’s controversial decision to say “yes” to a new drug to treat muscular dystrophy. US & World Videos 1:32 Amber Alert for 2 NH girls canceled, father in custody 2:53 Latest on Lewiston, Maine shootings 2:01 Local researchers looking to turn plastic into fuel 1:45 Gov. Healey to sign bottle ban order for state agencies 2:41 Leominster students return to school after floods
